Skip to main content Back to Top
Advertisement

6/18/2019

14.6% Sodium Chloride Concentrated Solution for Injection

Products Affected - Description

    • 14.6% Sodium Chloride solution for injection, Pfizer, 20 mL vial, 25 count, NDC 00409-6657-73
    • 14.6% Sodium Chloride solution for injection, Pfizer, 40 mL vial, 25 count, NDC 00409-6660-75

Reason for the Shortage

    • Pfizer has 14.6% sodium chloride concentrated solution for injection on shortage due to manufacturing delays.

Available Products

    • 14.6% Sodium Chloride solution for injection, Fresenius Kabi, 40 mL vial, 25 count, NDC 63323-0139-40

Estimated Resupply Dates

    • Pfizer has 14.6% sodium chloride concentrated solution for injection 20 mL vials on back order and the company estimates a release date of March 2020. The 40 mL vials are available in limited supply.

Updated

Updated June 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 19, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins